Skip to content

Text · Opinion parliamentary committee draft

On the draft Council decision on the conclusion of a broad package of agreements between the European Union, of the one part, and the Swiss Confederation, of the other part, to consolidate, deepen and expand their bilateral relations, and amending Decisions 2011/51/EU and 2011/738/EU

Full title

On the draft Council decision on the conclusion of a broad package of agreements between the European Union, of the one part, and the Swiss Confederation, of the other part, to consolidate, deepen and expand their bilateral relations, and amending Decisions 2011/51/EU and 2011/738/EU

Document SANT-PA-787758 · 10643/2025 – C100075/2026 – 2025/0162(NLE)

Kind
Opinion parliamentary committee draft SANT-PA-787758
Date
21 April 2026
Committee
Committee on Public Health
Rapporteur
Adam Jarubas
Dossier
2025-0162
More facts (3)
Subject matter
c_6f402b92
Reference
10643/2025 – C100075/2026 – 2025/0162(NLE)
More

In short

A summary of the text written by AI; ¶ opens the paragraph it rests on.

AI: In short Written by AI from the official text — check the source · deepseek-flash · 25 Sept 2026

The Committee on Public Health gives its consent to a broad package of agreements between the EU and the Swiss Confederation. It focuses on the Agreement on health and the Amending Protocol on mutual recognition in relation to conformity assessment. The health agreement makes Switzerland a full user of the Early Warning and Response System, includes it in joint procurement of medical countermeasures, and gives it participation in the Health Security Committee without voting rights. Switzerland joins the European Centre for Disease Prevention and Control, contributing financially and taking part in its Advisory Forum, networks and Management Board, without a vote on the Board. The mutual recognition protocol grants Switzerland observer status in the Committee on Medical Devices and the Medical Device Coordination Group, and observer participation in the Good Manufacturing and Distribution Practice Inspectors Working Group, while excluding it from the European Medicines Agency and from drafting EU medicinal product legislation. The committee calls on the Committee on Foreign Affairs to recommend approval of the draft Council decision concluding the package.

Position. The Committee on Public Health gives its consent to the broad package of agreements and calls on the Committee on Foreign Affairs to recommend approval of the draft Council decision concluding it.

Key points

  1. The Committee on Public Health gives its consent to the broad package of agreements with the Swiss Confederation.
  2. The Agreement on health creates a binding framework for cooperation on cross-border health crisis preparedness, disease prevention and regulatory oversight of medical devices and pharmaceuticals.
  3. Switzerland becomes a full rights user of the EU's Early Warning and Response System for surveillance.
  4. Switzerland is included in EU joint procurement procedures for medical countermeasures during health crises.
  5. Switzerland participates fully in the EU Health Security Committee, without voting rights.
  6. Switzerland participates structurally in the European Centre for Disease Prevention and Control, contributes financially, and takes part in its Advisory Forum, operational networks and Management Board, without a vote on the Board.
  7. The Amending Protocol on mutual recognition in relation to conformity assessment updates mutual recognition mechanisms to avoid duplication of procedures for products placed on the market.
  8. Switzerland receives observer status in the Committee on Medical Devices and the Medical Device Coordination Group established under Regulation (EU) 2017/745.
  9. Switzerland does not get the right to participate in the European Medicines Agency or in drafting EU medicinal product legislation.
  10. Switzerland may participate as an observer in the meetings of the Good Manufacturing and Distribution Practice Inspectors Working Group.
  11. The committee calls on the Committee on Foreign Affairs to recommend approval of the draft Council decision concluding the package.

Who is affected

  • Switzerland: gains full use of the Early Warning and Response System, joint procurement, and participation in the Health Security Committee and ECDC without votes.
  • EU and Swiss pharmaceutical and medical device sectors: benefit from updated mutual recognition and observer roles in relevant committees.
  • European Centre for Disease Prevention and Control: receives financial contributions from Switzerland and includes it in its bodies.
  • European Medicines Agency: Switzerland is excluded from participation.

Read the text · Report a problem

Text

The text as parsed from the official Word file. Every paragraph has a link (¶) and can be saved to a project as a passage.

Short justification

The Committee on Public Health gives its consent and supports the broad package of agreements to consolidate, deepen, and expand bilateral relations with the Swiss Confederation. Within this extensive package, two specific documents bear legal effect and form the basis for this committee's opinion: the Agreement on health, and the Amending Protocol to the Agreement on mutual recognition in relation to conformity assessment. These texts establish binding institutional frameworks, rules, and mutual obligations, explicitly governing EU-Swiss cooperation on cross-border health crisis preparedness, disease prevention, and the rigorous regulatory oversight of medical devices and pharmaceuticals.

Forming the primary basis for our endorsement is the Agreement on health. The Committee welcomes this dedicated agreement because it establishes a robust, legally binding framework for health security cooperation to prepare for, and respond to, serious cross-border threats to health. Crucially, it ensures a consistently high level of surveillance by integrating Switzerland as a full rights user of the EU's Early Warning and Response System (EWRS). Furthermore, it strengthens our collective supply chain during health crises by including Switzerland in the EU's joint procurement procedures for medical countermeasures, and it grants them full participation in the EU Health Security Committee, albeit without voting rights.

Additionally, this core agreement secures Switzerland’s structural participation in the European Centre for Disease Prevention and Control (ECDC), which is a core agency under this committee's remit. Switzerland will contribute financially to the agency and participate fully in its Advisory Forum and operational networks, as well as its Management Board, though explicitly without the right to vote in the latter. This deep integration ensures that both the Union and Switzerland can effectively prevent and respond to shared health threats.

The other central pillar of our endorsement is the Amending Protocol on mutual recognition in relation to conformity assessment. This protocol directly relates to the Committee on Public Health's competences regarding pharmaceuticals and medical devices. The committee welcomes this protocol because it updates mutual recognition mechanisms to avoid the duplication of procedures while certifying conformity to respective requirements for products placed on the market. Specifically, it formally grants Switzerland observer status in the Committee on Medical Devices and the Medical Device Coordination Group (MDCG), established under Regulation (EU) 2017/745 on medical devices.

Finally, the mutual recognition protocol carefully protects the Union's legislative autonomy regarding medicinal products. It explicitly stipulates that Switzerland does not get the right to participate in the European Medicines Agency (EMA) or in the drafting of EU medicinal product legislation. However, it makes an exception for Switzerland's participation as an observer in the meetings of the Good Manufacturing and Distribution Practice (GMDP) Inspectors Working Group. This allows for appropriate cross-border cooperation and consistent oversight on pharmaceutical manufacturing standards.

Considering these provisions, the structural integration of these public health policies and medical product safety standards warrants the full support of the Committee on Public Health, serving as the basis for our recommendation to give consent to the broad package of agreements.

*******

The Committee on Public Health calls on the Committee on Foreign Affairs, as the committee responsible, to recommend approval of the draft Council decision on the conclusion of a broad package of agreements between the European Union, of the one part, and the Swiss Confederation, of the other part, to consolidate, deepen and expand their bilateral relations, and amending Decisions 2011/51/EU and 2011/738/EU.

Connections

The dossier, the decisions on this text and its other versions.

No connections found for this item.

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Retrieved
25 September 2026

Cite as

European Parliament (2026). “DRAFT OPINION on the draft Council decision on the conclusion of a broad package of agreements between the European Union, of the one part, and the Swiss Confederation, of the other part, to consolidate, deepen and expand their bilateral relations, and amending Decisions 2011/51/EU and 2011/738/EU”. Text, 21 April 2026. docId SANT-PA-787758. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/texts/SANT-PA-787758 (retrieved 25 September 2026). Data: EP Open Data API: document record, https://data.europarl.europa.eu/api/v2/documents/SANT-PA-787758 (CC BY 4.0).
BibTeX
@misc{epw-text-sant-pa-787758,
  author = {{European Parliament}},
  title = {{DRAFT OPINION on the draft Council decision on the conclusion of a broad package of agreements between the European Union, of the one part, and the Swiss Confederation, of the other part, to consolidate, deepen and expand their bilateral relations, and amending Decisions 2011/51/EU and 2011/738/EU}},
  year = {2026},
  date = {2026-04-21},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/texts/SANT-PA-787758}},
  url = {https://news.eu-parl.st-solutions.dev/texts/SANT-PA-787758},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Text. docId SANT-PA-787758. Data: EP Open Data API: document record (CC BY 4.0)}
}